Table 1:
Baseline characteristics of participants by exercise group
Lower-dose (n = 25) |
Higher-dose (n = 24) |
|
---|---|---|
Age (years) | 65.3 ± 4.7 | 64.9 ± 4.2 |
Height (cm) | 162.3 ± 6.4 | 163.6 ± 6.3 |
Weight (kg) | ||
Baseline | 68.2 ± 9.8 | 68.1 ± 9.4 |
Post-intervention | 67.5 ± 9.6 | 66.8 ± 9.6* |
Fat mass (kg) | ||
Baseline | 27.2 ± 7.5 | 26.8 ± 6.5 |
Post-intervention | 26.4 ± 7.2* | 25.4 ± 6.7† |
Lean mass (kg) | ||
Baseline | 39.8 ± 3.8 | 40.0 ± 5.0 |
Post-intervention | 39.6 ± 3.6 | 39.7 ± 5.0 |
Body fat (%) | ||
Baseline | 38.6 ± 6.3 | 38.3 ± 6.6 |
Post-intervention | 38.1 ± 6.4 | 37.2 ± 6.9* |
VO2peak (ml•kg−1•min−1) | ||
Baseline | 20.6 ± 3.5 | 20.1 ± 3.5 |
Post-intervention | 21.7 ± 4.3 | 23.1 ± 5.2‡ |
Exercise time (minutes•week−1) | 105 ± 9 | 160 ± 14 |
Data are presented as mean ± SD.
, p < 0.05 compared to baseline value.
, p < 0.01 compared to baseline value.
, p < 0.0001 compared to baseline value.